Pentoxifylline improves insulin action limiting skeletal muscle catabolismafter infection

Citation
T. Vary et al., Pentoxifylline improves insulin action limiting skeletal muscle catabolismafter infection, J ENDOCR, 163(1), 1999, pp. 15-24
Citations number
31
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF ENDOCRINOLOGY
ISSN journal
00220795 → ACNP
Volume
163
Issue
1
Year of publication
1999
Pages
15 - 24
Database
ISI
SICI code
0022-0795(199910)163:1<15:PIIALS>2.0.ZU;2-L
Abstract
We investigated the ability of pentoxifylline (PTX) to modulate protein syn thesis and degradation in the presence and absence of insulin during incuba tion of epitrochlearis muscle, 2 or 6 days after injection of Escherichia c oli. On days 2 and 6 after infection, protein synthesis was inhibited by 25 %, whereas proteolysis was enhanced by 75%. Insulin (2 nM) in vitro stimula ted protein synthesis in muscles from infected rats to the same extent as i n controls. The ability of insulin to limit protein degradation was severel y blunted 48 h after infection. On day 6 after infection, insulin inhibited proteolysis to a greater extent than on day 2. PTX suppressed the increase in plasma concentrations of tumor necrosis factor more than 600-fold after injection of bacteria, and partially prevented the inhibition of protein s ynthesis and stimulation of protein degradation during sepsis. Moreover, PT X administration maintained the responsiveness of protein degradation to in sulin during sepsis. Thus cytokines may influence skeletal muscle protein m etabolism during sepsis, both indirectly through inhibition of the effects of insulin on proteolysis, and directly on the protein synthesis and degrad ation machinery.